DK1450770T3 - A pharmaceutical composition comprising a 5HT1 receptor agonist - Google Patents

A pharmaceutical composition comprising a 5HT1 receptor agonist

Info

Publication number
DK1450770T3
DK1450770T3 DK02792887T DK02792887T DK1450770T3 DK 1450770 T3 DK1450770 T3 DK 1450770T3 DK 02792887 T DK02792887 T DK 02792887T DK 02792887 T DK02792887 T DK 02792887T DK 1450770 T3 DK1450770 T3 DK 1450770T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
receptor agonist
agonist
receptor
pharmaceutical
Prior art date
Application number
DK02792887T
Other languages
Danish (da)
Inventor
Robert William Baker
Alan David Dow
Simon John Summers
Julian Westrup
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0129117.8A external-priority patent/GB0129117D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK1450770T3 publication Critical patent/DK1450770T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
DK02792887T 2001-12-05 2002-12-04 A pharmaceutical composition comprising a 5HT1 receptor agonist DK1450770T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0129117.8A GB0129117D0 (en) 2001-12-05 2001-12-05 Pharmaceutical composition
EP02792887A EP1450770B1 (en) 2001-12-05 2002-12-04 Pharmaceutical composition comprising a 5ht1 receptor agonist
EP0231715 2002-12-04

Publications (1)

Publication Number Publication Date
DK1450770T3 true DK1450770T3 (en) 2005-08-01

Family

ID=34424757

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02792887T DK1450770T3 (en) 2001-12-05 2002-12-04 A pharmaceutical composition comprising a 5HT1 receptor agonist

Country Status (2)

Country Link
DK (1) DK1450770T3 (en)
SI (1) SI1450770T1 (en)

Also Published As

Publication number Publication date
SI1450770T1 (en) 2005-08-31

Similar Documents

Publication Publication Date Title
HK1069111A1 (en) Pharmaceutical composition comprising a 5ht1 receptor agonist.
NO20032678D0 (en) NMDA receptor agonist pharmaceutical compositions
DK1446379T3 (en) Arylanilin-beta2-adrenergic receptor agonists
FI20011478A0 (en) Pharmaceutical composition
DK1615646T4 (en) PHARMACEUTICAL FORMULATIONS CONTAINING METHYLNALTREXONE
NO20033143D0 (en) Pharmaceutical preparation
ATE450505T1 (en) CB 1 RECEPTOR INVERSAGONISTS
HUP0402492A3 (en) 5ht4 partial agonist pharmaceutical compositions
NO20042737L (en) Peroxisome proliferator activated receptor agonists
ATE381541T1 (en) AMINOTETRALIN DERIVATIVES, ANTAGONISTS OF MUSCARINE RECEPTORS
DE60217390D1 (en) BICALUTAMIDE-CONTAINING PHARMACEUTICAL COMPOSITION
DE60324018D1 (en) AGONIST
DE10291905D2 (en) Pharmaceutical composition
NO20013978D0 (en) Dopamine D1 receptor agonist compounds
DK1450770T3 (en) A pharmaceutical composition comprising a 5HT1 receptor agonist
IS7581A (en) A pharmaceutical composition
EE200300465A (en) Pharmaceutical compositions based on pyridoindolone derivatives
EE200300378A (en) A pharmaceutical composition
FI20012242A0 (en) New pharmaceutical compounds
NO20041776L (en) A new G protein-coupled receptor, GAVE10
DK1347760T3 (en) Pharmaceutical compositions with NMDA receptor agonists
ITRM20030201A1 (en) SPHERICAL HINGE SUPPORT FOR BRIDGES,
NO20040252L (en) A new G protein-coupled receptor, GAVE8
FI5468U1 (en) Pharmaceutical composition
DOP2002000508A (en) PHARMACEUTICAL COMPOSITION